Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Johnson & Johnson investors can soon swap their shares for Kenvue stock — here's what you need to know
03:44pm, Thursday, 20'th Jul 2023
J&J owns nearly 90% of Kenvue shares and plans to reduce its stake in the company through an exchange offer that could launch "as early as the coming days."
Is Johnson & Johnson Giving Up on Kenvue (KVUE) Stock?
02:36pm, Thursday, 20'th Jul 2023
One of the more interesting moves in today's market comes from recent spinoff Kenvue (NYSE: KVUE ). Currently, shares of KVUE stock are down around 3% in today's session, as the company reported ear
These 2 Stocks Just Sent the Dow Jones Soaring
02:33pm, Thursday, 20'th Jul 2023
The Dow outpaced other market indexes on Thursday afternoon. Johnson & Johnson announced solid growth in the second quarter of 2023.
J&J (JNJ) Q2 Earnings & Sales Top, '23 View Upped, Stock Jumps
01:39pm, Thursday, 20'th Jul 2023
J&J (JNJ) beats estimates for second-quarter earnings and sales. It raises full-year sales and earnings guidance.
Markets Mixed at Midday on Weaker Earnings Reports
01:05pm, Thursday, 20'th Jul 2023
U.S. equites were mixed at midday on July 20, 2023 as weak earnings news, especially in the tech sector, held back gains.
What Stocks To Buy Today? 2 Dow Jones Industrial Average Stocks To Watch
12:31pm, Thursday, 20'th Jul 2023
Dow Jones Industrial Average stocks to watch in the stock market right now.
Johnson & Johnson stock up, CFO weighs in on earnings, demand, and company outlook
12:22pm, Thursday, 20'th Jul 2023
Johnson & Johnson CFO Joe Wolk tells Yahoo Finance Live that things like people catching up on surgical procedures as well as new products boosted the company's results. On the company's legal challen
J&J Beats Estimates and Boosts Outlook as Medtech Product Demand Grows
12:20pm, Thursday, 20'th Jul 2023
Shares of Johnson & Johnson advanced as the pharmaceutical and medical products firm posted better-than-expected results and raised its guidance on higher demand for its medtech products.
Johnson & Johnson Rips Off the Kenvue Band-Aid
12:06pm, Thursday, 20'th Jul 2023
A surprisingly early distribution and a stretched valuation hit J&J's consumer health arm hard.
Stock movers July 20, 2022: Johnson & Johnson, Kenvue, and Abbott Labs
11:38am, Thursday, 20'th Jul 2023
Johnson & Johnson, Kenvue, and Abbott Labs posted second quarter results that topped analyst estimates. Yahoo Finance Live anchors break down the market reaction to the report.
Johnson & Johnson's Inflection Point: What it Means for Investors
11:36am, Thursday, 20'th Jul 2023
After three years of waiting, Johnson & Johnson NYSE: JNJ shares have returned to trend, a monumental event for the market which presents a potential buying opportunity for income investors.
J&J spinoff Kenvue CEO on first full quarterly earnings results since IPO
11:34am, Thursday, 20'th Jul 2023
Thibaut Mongon, Kenvue CEO, joins 'Squawk on the Street' to discuss the company's quarterly earnings results, what Mongon is seeing from the consumer, and much more.
Why Johnson & Johnson Stock Is Rising Today
11:08am, Thursday, 20'th Jul 2023
The healthcare giant posted better-than-expected 2023 Q2 financial results today.
2 Ultra-Safe Dividend Stocks Retirees May Want to Consider Buying
11:07am, Thursday, 20'th Jul 2023
Dividend stocks often provide an important source of income for retirees. Target and Johnson & Johnson are two top-shelf dividend stocks suitable for risk-averse investors.
Johnson & Johnson (JNJ) Tops Q2 Earnings and Revenue Estimates
09:09am, Thursday, 20'th Jul 2023
Johnson & Johnson (JNJ) came out with quarterly earnings of $2.80 per share, beating the Zacks Consensus Estimate of $2.61 per share. This compares to earnings of $2.59 per share a year ago.
